A white label pharmacy, in the way telehealth founders use the term, is not a pharmacy you own. It is a network of independently licensed pharmacies that fill your affiliated providers' prescriptions and ship them to your patients in packaging and communication that carry your brand, while the pharmacy's own name, license number, and pharmacist-in-charge remain on the prescription label as the law requires. The white label pharmacy model exists because building your own pharmacy means state permits, non-resident licenses, a pharmacist-in-charge, sterile compounding infrastructure, and LegitScript review, none of which a brand wants to build before it has a paying patient.
This guide covers how the model works: 503A and 503B routing, state licensure, cold chain, LegitScript, 0% markup economics, what the brand does and does not control, and the red flags. This is general information, not legal or medical advice.
Key takeaways
- A white label pharmacy for telehealth is branded fulfillment through licensed partner pharmacies, not a pharmacy the brand owns; the dispensing pharmacy's identity stays on the prescription label by law.
- Prescriptions are routed per order across 503A pharmacies (patient-specific) and, for clinic stock, 503B outsourcing facilities, matched to the patient's state, the product, and cold-chain requirements.
- A pharmacy can only ship into states where it holds a resident or non-resident license, so the combined licensing footprint of the network caps the brand's serviceable market.
- Pass-through pricing with 0% markup means the brand pays what the pharmacy charges and keeps its own margin; hidden per-unit markup is the most common way the economics quietly go wrong.
- The brand controls storefront, pricing, patient communication, and unboxing; the pharmacy controls the prescription label, counseling, substitution, and compliance decisions.
What is a white label pharmacy and how does it differ from owning one?
Two different things are sold under the phrase "white label pharmacy" as of September 2026.
Branded fulfillment through partner pharmacies. Your providers e-prescribe. The prescription routes to a licensed pharmacy with a permit for the patient's state, which compounds or dispenses, applies its own compliant label, and ships in a box carrying your brand: your insert, your onboarding card, your support number. The patient experiences your brand; the pharmacy experiences a normal prescription. This is what telehealth infrastructure platforms mean by white label pharmacy, and it is what this article is about.
Owning or leasing a pharmacy. Some operators buy or build a compounding pharmacy so they control formulation, margin, and capacity. That is a real business, but it comes with a resident pharmacy license, a pharmacist-in-charge, USP 795 and 797 compliance, DEA registration for controlled substances, state-by-state non-resident licensing, and its own LegitScript certification. It also raises a self-dealing question, since several states restrict prescriber ownership interest in pharmacies. Most brands that go this route do it after they have volume, not before.
Owning converts a variable cost into a fixed cost and a compliance program; partnering converts it into a per-order pass-through. Until you know your demand curve, the second is the rational choice, and it is the one this guide assumes.
How does prescription routing work across 503A and 503B pharmacies?
Every compounded medication in the US comes from one of two legal categories, and a white label pharmacy network has to route between them correctly. A 503A pharmacy compounds for a named patient under an individual prescription, overseen mainly by the state board of pharmacy. A 503B outsourcing facility registers with FDA, follows CGMP, and can produce batches without patient-specific prescriptions for office use. Our 503A vs 503B explainer covers the legal detail; the routing consequence is what matters here.
For a direct-to-consumer brand, almost every order is a 503A order: a patient-specific prescription filled by a 503A pharmacy licensed in that patient's state. If you also run a clinic or med spa that administers stocked medication on site, that inventory comes through a 503B rail, labeled "Office Use Only" as federal law requires when it is not tied to an individual prescription.
A competent white label pharmacy layer therefore does three things per order:
- State match. Which pharmacies in the network hold a license for the destination state.
- Product match. Which of those pharmacies compound this formulation, in this strength, in this format (injectable, troche, topical, oral).
- Logistics match. Which of those can ship it with the right cold chain and turnaround, and at what cost.
On MyOrbitHealth, OrbitRx routes e-prescriptions via Surescripts across a LegitScript-certified pharmacy network of compounding and retail partners, so a brand launching in twelve states does not negotiate twelve pharmacy contracts. For GLP-1 programs, routing also has to respect that FDA declared the semaglutide shortage resolved in February 2025 and ended enforcement discretion for 503A and 503B copies that spring; a compounded GLP-1 order in 2026 needs a clinical justification for why it differs from the approved product, and the pharmacy is the one that has to defend it.
Why does state licensure decide your launch map?
A pharmacy may only ship a filled prescription to a patient in a state where it holds that state's resident or non-resident pharmacy license. The shipment itself creates the obligation. Each state board sets its own non-resident application, usually requiring the home-state license in good standing, a pharmacist-in-charge, and a recent inspection report; NABP's Verified Pharmacy Program lets some boards accept a shared inspection, but not all do.
First, "we ship nationwide" is a claim about the network, not any one pharmacy. Ask which pharmacy covers which state, in writing, and what happens when the only licensed partner for a state is backed up. Our guide to compounding pharmacy partnerships has the vetting questions.
Second, controlled substances add a layer. Testosterone is Schedule III. Prescribing it via telehealth without an in-person visit depends on DEA's telemedicine flexibilities, which DEA and HHS extended through December 31, 2026 while permanent rules are finalized. The filling pharmacy needs DEA registration and, in several states, a separate controlled-substance registration; the prescriber needs EPCS with two-factor identity proofing. A TRT brand has to evaluate controlled-substance coverage separately from compounding coverage; the two maps are not the same.
What does cold chain mean for a white label pharmacy?
Injectable GLP-1s, most peptides, and some hormone preparations are temperature-sensitive. USP General Chapter 1079 sets storage and shipping practice for them across every party in the chain, including compounding pharmacies and carriers. Controlled cold temperature means 2 to 8 degrees Celsius, with only limited, documented excursions permitted, and every excursion is supposed to be assessed rather than waved through.
For the brand this translates into yes-or-no questions:
- Is the packaging qualified for the transit time to the patient's climate, in August and in January?
- Is there a temperature indicator in the box, and does the patient know how to read it?
- Who pays for the reship when a package sits on a porch in Phoenix for six hours, and how fast does it go out?
- Are shipments held on Fridays to avoid weekend dwell, and does the storefront say so before checkout?
The pharmacy owns the excursion decision; the brand owns the patient's expectation. If the contract does not define the reship policy, a support thread will, one refund at a time.
What does "LegitScript-certified pharmacy network" actually mean?
LegitScript's Healthcare Merchant Certification is the standard that Google and Meta rely on before they will serve prescription-drug and telehealth ads in the US. It applies to online pharmacies, compounding pharmacies, and telemedicine providers. For a brand, that means two separate certifications are in play.
The pharmacies hold their own certification, which is what "LegitScript-certified pharmacy network" refers to. The brand needs its own certification as a telemedicine merchant to run paid acquisition; the pharmacy's certificate is not a substitute, and the brand's application is reviewed partly on its pharmacy relationships and prescribing practices. Our LegitScript certification guide walks through the process; MyOrbitHealth prepares, files, and manages the brand's application through approval, and once filed the typical wait has been measured in days rather than months, though LegitScript sets its own timeline and approval is not guaranteed.
A brand cannot be certified on top of an uncertified pharmacy. If a partner cannot name which of its pharmacies are certified, assume none are.
Who pays what: pass-through economics and 0% markup
Medication cost is usually the largest variable cost in a prescription telehealth business, larger than the platform fee or the provider visit. There are three common models as of September 2026.
| Model | How the brand is charged for medication | Where the platform earns | What to check |
|---|---|---|---|
| Pass-through, 0% markup | Pharmacy's price, invoiced at cost | Flat platform fee | Confirm the pharmacy invoice is visible to the brand |
| Marked-up medication | Pharmacy price plus a per-unit margin | The markup, often undisclosed | Ask for the pharmacy's list price and compare |
| Revenue share | Percentage of each patient payment | The percentage, on medication and visits | Model it at 5x current volume |
MyOrbitHealth runs the first model: a flat platform fee scoped at onboarding, 0% medication markup, no revenue share, the brand as merchant of record, and the brand owning its patients and its data. The brand's gross margin is set by its retail price and the pharmacy's cost, with nothing in between, and the brand can see the pharmacy invoice, which is the only way to verify a 0% markup claim.
What does the brand control, and what does it not?
| Element | Brand controls | Pharmacy controls |
|---|---|---|
| Storefront, pricing, subscription terms | Yes | No |
| Outer packaging, inserts, unboxing | Yes, within the pharmacy's compliance review | Reviews for claims and required notices |
| Prescription label (drug, strength, directions, pharmacy name, Rx number) | No | Yes, by law |
| Substitution or formulation change | No | Yes, with prescriber approval |
| Pharmacist counseling and drug-interaction review | No | Yes |
| Patient communication about orders, shipping, renewals | Yes | Pharmacy handles medication-specific questions |
| Adverse event reporting | Routes through provider and pharmacy | Yes |
| Prescribing decision | No (providers are independent clinicians) | No (pharmacist reviews, does not prescribe) |
Two points deserve emphasis. First, the prescription label is not white label. Federal and state law require the dispensing pharmacy's name, address, and the prescriber's name on it, and the pharmacist's counseling obligation runs directly to the patient. A partner promising "your name on the vial" is describing a labeling violation. Second, the brand does not choose the drug. The brand sets a menu of programs, the provider decides what to prescribe, and the pharmacy decides whether it can lawfully fill it. That separation is what keeps a non-clinician founder on the right side of corporate practice of medicine rules.
Within those limits the brand has real room: unboxing, onboarding content, renewal reminders, refill cadence, and the tone of every message. On MyOrbitHealth, order status, tracking, and refill events surface through the branded storefront, native iOS and Android app, and webhooks, so the patient never sees the pharmacy's portal.
What are the red flags in a white label pharmacy offer?
The following should stop the conversation until they are answered.
- No state-by-state license list. "Nationwide" without a table means someone has not checked.
- Medication pricing you cannot trace to a pharmacy invoice. If the platform will not show you the pharmacy's price, assume a markup.
- A single pharmacy behind the whole network. One point of failure for capacity, licensing lapses, and inspection findings.
- Compounded GLP-1s with no clinical-difference rationale. After the 2025 shortage resolution, that is enforcement risk the brand inherits.
- Promises about the label, counseling, or substitution. These belong to the pharmacy by law.
- LegitScript "assistance" described as certification. Ask whether the pharmacies are certified and whether the platform will file and manage the brand's own application.
- Revenue share disguised as a low platform fee. Model the total cost at the volume you hope to reach, not the volume you have.
The white-label telehealth platform guide covers the rest of the stack, and the best white-label telehealth platforms roundup puts the pharmacy models side by side.
How does a white label pharmacy fit into the rest of the launch?
Pharmacy is the last mile, downstream of everything else. The patient completes a branded intake (Orbit Intake on MyOrbitHealth). A licensed provider in the patient's state decides whether to prescribe; MyOrbitHealth's Provider Network covers all 50 states with 2,400+ board-certified providers across 38+ specialties, averaging under six minutes to respond during business hours. If labs are needed, Orbit Labs draws them via a Quest or Labcorp order slip, a Tasso at-home kit, or mobile phlebotomy. The prescription transmits electronically, with EPCS for controlled substances, routes to a matched network pharmacy, and ships in the brand's packaging, with refills recurring on the brand's subscription as merchant of record.
That is what a white label pharmacy arrangement buys: not a pharmacy, but a pharmacy layer that already exists, holds its licenses, and answers to the right regulators.
Frequently asked questions
What is a white label pharmacy?
A white label pharmacy is a licensed partner pharmacy, or network of them, that fills a telehealth brand's prescriptions and ships them in the brand's packaging and communication. The pharmacy's own name and license remain on the prescription label as required by law; the brand controls the storefront, pricing, unboxing, and patient messaging.
Can a telehealth brand put its own name on the prescription label?
No. Federal and state pharmacy law require the dispensing pharmacy's name, address, and the prescriber's name on the prescription label. The brand can control outer packaging, inserts, and communication, but not the label itself. A partner promising otherwise is describing a compliance violation.
Does a white label pharmacy need a license in every state I sell into?
Yes. A pharmacy can only ship a filled prescription into a state where it holds a resident or non-resident pharmacy license from that state's board. Multi-state brands rely on a network of pharmacies whose combined licenses cover the map, with routing that picks the right pharmacy per order.
What does 0% medication markup mean in a white label pharmacy model?
It means the brand pays the pharmacy's actual price for each medication, with no per-unit margin added by the platform in between. The platform earns a flat fee instead. The only way to verify a 0% markup claim is to see the pharmacy's invoice, so ask whether that visibility is part of the arrangement.
Is a compounded GLP-1 still available through a white label pharmacy in 2026?
FDA declared the semaglutide shortage resolved in February 2025 and the tirzepatide shortage resolved before that, ending the broad flexibility that allowed compounded copies. As of September 2026, a compounded GLP-1 prescription needs a patient-specific clinical reason it differs from the approved product, and the pharmacy must be able to defend that. Get your pharmacy partner's current written position before building a program around it.
How is a white label pharmacy different from private label telemedicine?
Private label telemedicine usually describes the whole branded clinic: intake, providers, storefront, and app running under the brand's name on someone else's infrastructure. The white label pharmacy is the fulfillment layer inside that clinic. A brand can run private label telemedicine without a pharmacy layer, but any prescription program needs both.
See the pharmacy map for your launch states
MyOrbitHealth brands launch on a LegitScript-certified pharmacy network with OrbitRx routing every prescription by state, product, and cold chain, at 0% medication markup, no revenue share, and with the brand as merchant of record. Book a demo to walk through the pharmacy coverage and economics for the states and products you plan to sell.